
Sign up to save your podcasts
Or


Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.
By Tensor Black4.3
1414 ratings
Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.

4,368 Listeners

21,241 Listeners

2,080 Listeners

112,351 Listeners

8,474 Listeners

4,063 Listeners

9,290 Listeners

8,187 Listeners

6,056 Listeners

805 Listeners

29,178 Listeners

531 Listeners

1,194 Listeners

557 Listeners

3,101 Listeners